Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Drug Discovery Today
|
December 3, 2024
Learning from European regulator-initiated studies for regulatory decision making
Stefan Verweij, Just Weemers, Carla Jonker, et al.
Clinical Pharmacology and Therapeutics
|
February 12, 2024
A Natural Language Processing Approach Towards Harmonized Communication of Uncertainties Identified During the European Medicine Authorization Process
Stefan Verweij, Vincent Haverhoek, Erik Bergman, et al.
Health Promotion International
|
October 18, 2017
Implementing multiple intervention strategies in Dutch public health-related policy networks
Janneke Harting, Dorothee Peters, Kimberly Grêaux, et al.
Applied Health Economics and Health Policy
|
November 16, 2023
Comment on: "The Assessment of Patient-Reported Outcomes for the Authorisation of Medicines in Europe: A Review of European Public Assessment Reports from 2017 to 2022"
Sieta T de Vries, Noral Huda S Al-Mugoter, Irena Petkoska, et al.
Vaccine
|
August 1, 2023
Variability of in vivo potency assays of whole-cell pertussis, inactivated polio, and meningococcal B vaccines
Cerissa van Walstijn, Stefan Verweij, Rory Care, et al.
European Journal of Epidemiology
|
March 18, 2026
A target trial emulation of the CONFIRM study with an extension to subgroups: an example for relapsing-remitting multiple sclerosis
Stefan Verweij, Maarten J Bijlsma, Katrien Oude Rengerink, et al.
Pharmacoepidemiology and Drug Safety
|
May 9, 2024
Do efficacy results obtained from randomized controlled trials translate to effectiveness data from observational studies for relapsing-remitting multiple sclerosis?
Stefan Verweij, Wouter Ahmed, Guiling Zhou, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society
|
February 19, 2025
Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection and severe outcomes in adults: a systematic review and meta-analysis of European studies published up to 22 January 2024
Guiling Zhou, Nina Dael, Stefan Verweij, et al.
BMJ Open Respiratory Research
|
August 28, 2023
Repurposed drug studies on the primary prevention of SARS-CoV-2 infection during the pandemic: systematic review and meta-analysis
Guiling Zhou, Stefan Verweij, Maarten J Bijlsma, et al.
Pharmaceuticals (Basel, Switzerland)
|
June 26, 2026
Repurposing Candidate Drugs to Prevent SARS-CoV-2: A PharmLines Test-Negative Case-Control Study
Guiling Zhou, Nina Dael, Stefan Verweij, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Drug Discovery Today
|
December 3, 2024
Learning from European regulator-initiated studies for regulatory decision making
Stefan Verweij, Just Weemers, Carla Jonker, et al.
Clinical Pharmacology and Therapeutics
|
February 12, 2024
A Natural Language Processing Approach Towards Harmonized Communication of Uncertainties Identified During the European Medicine Authorization Process
Stefan Verweij, Vincent Haverhoek, Erik Bergman, et al.
Health Promotion International
|
October 18, 2017
Implementing multiple intervention strategies in Dutch public health-related policy networks
Janneke Harting, Dorothee Peters, Kimberly Grêaux, et al.
Applied Health Economics and Health Policy
|
November 16, 2023
Comment on: "The Assessment of Patient-Reported Outcomes for the Authorisation of Medicines in Europe: A Review of European Public Assessment Reports from 2017 to 2022"
Sieta T de Vries, Noral Huda S Al-Mugoter, Irena Petkoska, et al.
Vaccine
|
August 1, 2023
Variability of in vivo potency assays of whole-cell pertussis, inactivated polio, and meningococcal B vaccines
Cerissa van Walstijn, Stefan Verweij, Rory Care, et al.
European Journal of Epidemiology
|
March 18, 2026
A target trial emulation of the CONFIRM study with an extension to subgroups: an example for relapsing-remitting multiple sclerosis
Stefan Verweij, Maarten J Bijlsma, Katrien Oude Rengerink, et al.
Pharmacoepidemiology and Drug Safety
|
May 9, 2024
Do efficacy results obtained from randomized controlled trials translate to effectiveness data from observational studies for relapsing-remitting multiple sclerosis?
Stefan Verweij, Wouter Ahmed, Guiling Zhou, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society
|
February 19, 2025
Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection and severe outcomes in adults: a systematic review and meta-analysis of European studies published up to 22 January 2024
Guiling Zhou, Nina Dael, Stefan Verweij, et al.
BMJ Open Respiratory Research
|
August 28, 2023
Repurposed drug studies on the primary prevention of SARS-CoV-2 infection during the pandemic: systematic review and meta-analysis
Guiling Zhou, Stefan Verweij, Maarten J Bijlsma, et al.
Pharmaceuticals (Basel, Switzerland)
|
June 26, 2026
Repurposing Candidate Drugs to Prevent SARS-CoV-2: A PharmLines Test-Negative Case-Control Study
Guiling Zhou, Nina Dael, Stefan Verweij, et al.
Page
of 2